Friday, 16 October 2026European Markets

IPSOS And ADP Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - ipsos (ips.pa) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
ipsos (ips.pa) €65.00 2.99% 13.83%
adp (adp.pa) €126.20 2.66% 13.28%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ipsos (ips.pa)

2.99% forward dividend yield and 13.83% return on equity

ipsos sa, through its subsidiaries, provides survey-based research services for companies and institutions in europe, the middle east, africa, the americas, and the asia-pacific. the company offers services in the information production and analysis chain, including data collection, data processing and integration, data analysis, information delivery and presentation, and information activation. it also provides audience measurement, automotive and mobility development, brand health tracking, channel performance, corporate reputation, creative excellence, customer experience, healthcare, innovation, ipsos mma, ipsos uu, market strategy and understanding, observer, public affairs, social intelligence analytics, and other specialist services, as well as research methodologies, such as device agnosticism, programmatic sampling, and digital face-to-face interview. in addition, the company offers online and mobile integrated services and device agnostic solutions that include online surveys adapted to laptops, smartphones, and tablets; and qualitative research services, as well as operates ipsos.digital, a do-it-yourself platform. further, it provides artificial intelligence and data science solutions that develops and provides analytical tools based on data science, machine learning, big analytics, and modelling; and behavioral science and neuroscience solutions, as well as operates ipsos knowledge centre for teams and clients. ipsos sa was incorporated in 1975 and is headquartered in paris, france.

earnings per share

as for profitability, ipsos has a trailing twelve months eps of €3.59.

pe ratio

ipsos has a trailing twelve months price to earnings ratio of 18.11. meaning, the purchaser of the share is investing €18.11 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.83%.

more news about ipsos.

2. adp (adp.pa)

2.66% forward dividend yield and 13.28% return on equity

aeroports de paris sa owns and operates airports worldwide. the company operates through aviation, retail and services, real estate, international and airport developments, and other activities segments. the aviation segment provides security and airport safety services, including security checkpoints, screening systems, aircraft rescue, and fire-fighting services. the retail and services segment engages in the retail activities, including bars, restaurants, banks, car rentals, and retails shops, as well as leases space for terminals, advertising, restaurant, and car park services. this segment also engages in the production and supply of heat, drinking water, and access to the chilled distribution networks. the real estate segment engages in the construction, commercialization, and lease management of office buildings, logistic buildings, and freight terminals; and provides property leasing services for airport terminals, as well as rents serviced land. the international and airport developments segment designs and operates airport activities. the other activities segment offers telecom and cybersecurity services. aeroports de paris sa was incorporated in 1945 and is based in tremblay-en-france, france.

earnings per share

as for profitability, adp has a trailing twelve months eps of €6.39.

pe ratio

adp has a trailing twelve months price to earnings ratio of 19.75. meaning, the purchaser of the share is investing €19.75 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.28%.

volatility

adp's last week, last month's, and last quarter's current intraday variation average was a negative 0.18%, a negative 0.08%, and a positive 1.25%.

adp's highest amplitude of average volatility was 1.39% (last week), 0.95% (last month), and 1.25% (last quarter).

dividend yield

according to morningstar, inc., the next dividend payment is on jun 5, 2023, the estimated forward annual dividend rate is 3.13 and the estimated forward annual dividend yield is 2.66%.

yearly top and bottom value

adp's stock is valued at €126.20 at 16:30 est, way under its 52-week high of €147.70 and way above its 52-week low of €100.00.

volume

today's last reported volume for adp is 21305 which is 75.29% below its average volume of 86229.

more news about adp.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com